(Q34674712)

3 August 2017

1 reference

title

What do we want from proteomics in the detection and avoidance of adverse drug reactions (English)

1 reference

3 August 2017

Wilkins MR

1

1 reference

3 August 2017

publication date

1 February 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

127

1 reference

3 August 2017

issue

1-3

1 reference

3 August 2017

page(s)

245-249

1 reference

New insights into cyclosporine A nephrotoxicity by proteome analysis

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2801%2900506-9

7 January 2021

The effects of peroxisome proliferators on protein abundances in mouse liver

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2801%2900506-9

7 January 2021

The use of skin testing in the investigation of cutaneous adverse drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2801%2900506-9

7 January 2021

Skin testing in systemic cutaneous drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2801%2900506-9

7 January 2021

Adverse drug reactions: definitions, diagnosis, and management

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2801%2900506-9

7 January 2021

Proteins of rat serum IV. Time-course of acute-phase protein expression and its modulation by indomethacine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2801%2900506-9

7 January 2021

Proteomic profiling from human samples: the body fluid alternative

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2801%2900506-9

7 January 2021

Comparison of the Bayesian approach and a simple algorithm for assessment of adverse drug events.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2801%2900506-9

7 January 2021

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2801%2900506-9

7 January 2021

Pharmacogenetics and the practice of medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2801%2900506-9

7 January 2021

Proteomics: applications and opportunities in preclinical drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2801%2900506-9

7 January 2021

A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2801%2900506-9

7 January 2021

10.1016/S0378-4274(01)00506-9

Identifiers

DOI

1 reference

3 August 2017

1 reference